For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
Exelixis Inc (NASDAQ: EXEL) closed the day trading at $36.81 down -1.21% from the previous closing price of $37.26. In other words, the price has decreased by -$1.21 from its previous closing price. On the day, 4.24 million shares were traded. EXEL stock price reached its highest trading level at $37.58 during the session, while it also had its lowest trading level at $36.45.
Ratios:
For a better understanding of EXEL, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 12.53 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 13.14. For the most recent quarter (mrq), Quick Ratio is recorded 3.44 and its Current Ratio is at 3.51. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, RBC Capital Mkts on July 08, 2025, Downgraded its rating to Sector Perform and sets its target price to $50 from $45 previously.
On June 24, 2025, Stephens Upgraded its rating to Overweight which previously was Equal-Weight but kept the price unchanged to $60.
Wells Fargo Downgraded its Overweight to Equal Weight on February 24, 2025, while the target price for the stock was maintained at $36.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Jun 02 ’25 when Eckhardt Sue Gail sold 18,838 shares for $42.74 per share. The transaction valued at 805,140 led to the insider holds 21,380 shares of the business.
WYSZOMIERSKI JACK L sold 7,535 shares of EXEL for $324,683 on Jun 03 ’25. The Director now owns 358,882 shares after completing the transaction at $43.09 per share. On Jun 03 ’25, another insider, JACK L WYSZOMIERSKI, who serves as the Director of the company, bought 7,535 shares for $43.09 each.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 9909362688 and an Enterprise Value of 9298088960. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.65, and their Forward P/E ratio for the next fiscal year is 11.43. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.53. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.44 while its Price-to-Book (P/B) ratio in mrq is 4.89. Its current Enterprise Value per Revenue stands at 4.17 whereas that against EBITDA is 11.897.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.32, which has changed by 0.5697228 over the last 52 weeks, in comparison to a change of 0.20799685 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $49.62, while it has fallen to a 52-week low of $23.21. The 50-Day Moving Average of the stock is -14.00%, while the 200-Day Moving Average is calculated to be -1.37%.
Shares Statistics:
Over the past 3-months, EXEL traded about 3.71M shares per day on average, while over the past 10 days, EXEL traded about 5298100 shares per day. A total of 270.13M shares are outstanding, with a floating share count of 260.58M. Insiders hold about 3.20% of the company’s shares, while institutions hold 93.99% stake in the company. Shares short for EXEL as of 1752537600 were 18267722 with a Short Ratio of 4.92, compared to 1749772800 on 20385497. Therefore, it implies a Short% of Shares Outstanding of 18267722 and a Short% of Float of 9.3100004.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
